As of August 31, 2020, we owned or leased the following facilities (square footage in thousands):
−Removed: Number of Locations
−Removed: Square Footage
+Added: Number of Locations Square Footage
Distribution /
−Removed: Manufacturing
+Added: Manufacturing Total Owned Leased Total
Industrial Tools & Services 13 35 48 213 988 1,201
−Removed: Engineered Components & Systems*
Corporate and Other 5 5 10 353 384 737
−Removed: * These owned locations are currently classified as "Assets from discontinued operations" on our Consolidated Balance Sheet and we anticipate divesting these facilities prior to the end of calendar 2019.
−Removed: The leases associated with these facilities will be assumed or bought out by the buyer of the EC&S segment.
+Added: 18 40 58 566 1,372 1,938
We consider our facilities suitable and adequate for the purposes for which they are used and do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.
−Removed: Our largest facilities associated with our continuing operations are located in the United States, China, the United Kingdom, the Netherlands and Spain.
−Removed: We also maintain a presence in Australia, Azerbaijan, Brazil, Germany, India, Italy, Japan, Kazakhstan, Singapore, South Africa, South Korea and
−Removed: the United Arab Emirates.
+Added: Our largest facilities are located in the United States, the United Kingdom, China, the Netherlands and Spain.
+Added: We also maintain a presence in Australia, Azerbaijan, Brazil, France, Germany, India, Italy, Japan, Kazakhstan, Norway, Singapore, South Africa, South Korea and the United Arab Emirates.
See Note 10, “Leases” in the notes to the consolidated financial statements for information regarding our lease commitments.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.